Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy

NCT01805830 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: MP513
DRUG: Placebo

Sponsor

Handok Inc.